PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
12160840-0	2002	GATA transcription in a small rhodamine 123(low)CD34(+) subpopulation of a peripheral blood-derived CD34(-)CD105(+) mesenchymal cell line.	Rhodamines	30-39	CD34 molecule	Homo sapiens	48-52	
21729546-7	2011	The acidification resulted in the increased rhodamine 123 accumulation in HL-60, MSC and CD34(+) cells without P-gp activity.	Rhodamines	44-53	CD34 molecule	Homo sapiens	89-93	
12160840-0	2002	GATA transcription in a small rhodamine 123(low)CD34(+) subpopulation of a peripheral blood-derived CD34(-)CD105(+) mesenchymal cell line.	Rhodamines	30-39	CD34 molecule	Homo sapiens	100-104	
12063025-0	2002	Myeloid-lymphoid initiating cells (ML-IC) are highly enriched in the rhodamine-c-kit(+)CD33(-)CD38(-) fraction of umbilical cord CD34(+) cells.	Rhodamines	69-78	CD34 molecule	Homo sapiens	129-133	
9557616-7	1998	In mobilized PB 54% of the CD34+ cells (n=5) were rhodamine dull compared to 22% in steady-state BM (P=0.014) [n=6].	Rhodamines	50-59	CD34 molecule	Homo sapiens	27-31	
10498614-3	1999	Normal CD34(+) progenitors showed rhodamine efflux in 20% to 30% of the cells, which could be blocked by verapamil.	Rhodamines	34-43	CD34 molecule	Homo sapiens	7-11	
10498614-6	1999	Triggering rhodamine dull (RhoD) CD34(+) cells to proliferate indeed resulted in a higher rhodamine retention and significantly decreased efflux modulation by verapamil (P =.04).	Rhodamines	11-20	CD34 molecule	Homo sapiens	33-37	
10498614-6	1999	Triggering rhodamine dull (RhoD) CD34(+) cells to proliferate indeed resulted in a higher rhodamine retention and significantly decreased efflux modulation by verapamil (P =.04).	Rhodamines	90-99	CD34 molecule	Homo sapiens	33-37	
8781417-9	1996	In stroma-free cultures, TPO activated a quiescent CD34+Lin-Rhodamine 123lo subset of primitive hematopoietic progenitor cells into cycle, without loss of CD34 expression.	Rhodamines	60-69	CD34 molecule	Homo sapiens	51-55	
8913436-5	1996	Mifepristone, when used at a 10 microM concentration thought to be achievable in vivo without major toxicity, was also able to markedly decrease cellular rhodamine 123 efflux occurring in CD34+ blast cells isolated from six patients suffering from myeloid acute leukemias.	Rhodamines	154-163	CD34 molecule	Homo sapiens	188-192	
8695847-2	1996	Heterogeneous rhodamine staining is seen within the CD34+ population, and the staining patterns differ dramatically between fetal BM (FBM), adult BM (ABM) and mobilized peripheral blood (MPB).	Rhodamines	14-23	CD34 molecule	Homo sapiens	52-56